N/A
Completed N=314
Rollover Protocol for Prior SU011248 Protocols
Source: ClinicalTrials.gov NCT00798889 ↗Enrolled (actual)
314
Serious AEs
37.9%
Results posted
Jan 2013
Primary outcomePrimary: Duration of Treatment — 190 Days
Summary
The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Treatment |
190 | — |
Eligibility Criteria
Inclusion Criteria
- Prior SU011248 Protocol.
- Eligible to continue SU011248 treatment.
Exclusion Criteria
- Uncontrolled CNS metastasis.
- Unfit to receive SU011248.
Data sourced from ClinicalTrials.gov (NCT00798889). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.